Houlihan Lokey, Inc. (HLI) Down 6.5% — Should I Accept This Outcome and Sell?

Key Points


  • HLI fell 6.49% to $168.81 from $180.53 previous trading day
  • Weiss Ratings assigns C (Hold)
  • Stock trades 20.3% below its 52-week high of $211.78 reached on 09/23/2025

Houlihan Lokey, Inc. (HLI) was under heavy pressure in the latest session, sliding 6.49% to close at $168.81, retreating from the prior close of $180.53 and losing $11.72 in market value per share. The stock is now sharply off its 52‑week peak of $211.78 set on Sept. 23, 2025, leaving it more than $40 below that high and reinforcing a pattern of losing ground from earlier strength. Trading activity was elevated, with volume surging to 1,377,380 shares, roughly triple its 90‑day average of 452,210, signaling that the latest move came amid intensified selling interest rather than thin trading.

This negative price action stands out in the broader Financials sector, where peers such as Berkshire Hathaway, Goldman Sachs, and Charles Schwab have generally shown more resilience in recent months. While those names have experienced their own bouts of volatility, Houlihan Lokey’s recent retreat places it closer to the lower end of its recent trading range and underscores that the stock is facing more persistent headwinds. With the shares now firmly below their recent highs and under pressure on heavier-than-normal volume, recent sessions point to a market that is reassessing the stock and, at least for now, leaning toward the sellers’ side of the ledger.


Why Houlihan Lokey, Inc. Price is Moving Lower

Despite a recent stretch of strong gains and a solid earnings beat, Houlihan Lokey, Inc. is facing growing pressure as investors reassess how much they are willing to pay for that strength. The stock has rallied sharply from the mid-$180s in mid-January to the low-$190s by Jan. 22, extending a broader move that followed better‑than‑expected quarterly results, including $2.14 in EPS versus $1.68 estimated and revenue of $605.35 million. With revenue growth running at a healthy 14.70% and profit margins of 16.62%, much of the good news is already reflected in the price after the prior all‑time high near $211. As the stock grinds lower from recent peaks, the weakness is being attributed less to fundamentals and more to concerns that expectations and valuation have run ahead of what is typical for financial services names.

The elevated trading volumes — repeatedly exceeding recent norms and peaking at over 550,000 shares in a single session — suggest institutional investors are using strength to trim positions and lock in profits. That creates a near‑term supply overhang, putting downward pressure on the share price even as operations remain solid. At the same time, sector peers such as Berkshire Hathaway (BRKA,), Goldman Sachs (GS), and Charles Schwab (SCHW) offer alternative exposure to Financials with potentially more balanced risk/reward profiles after HLI’s outsized run. In this context, caution is warranted: Any moderation in deal activity, advisory fees, or capital markets conditions could hit a stock that is already pricing in continued double‑digit growth, leaving limited margin for error if the operating environment cools.


What is the Houlihan Lokey, Inc. Rating - Should I Sell?

Weiss Ratings assigns HLI a C rating. Current recommendation is Hold. That middle-of-the-road assessment signals a stock where risk and reward are finely balanced — and where downside risk should not be underestimated. Despite operating in a profitable niche within Financials, Houlihan Lokey’s overall profile does not justify a Buy rating at this time.

On the positive side, HLI posts a solid 14.70% revenue growth rate and a healthy 16.62% profit margin, supported by an Excellent Efficiency Index and an Excellent Solvency Index. A 20.29% return on equity confirms management’s ability to generate attractive returns on capital. However, those strengths come at a price: The stock trades at a forward P/E of 29.11, which is demanding for a company with only a Fair Growth Index and a Fair Total Return Index. In other words, investors are paying a growth multiple for what has been only middling performance.

The Weak Dividend Index further undercuts the case for owning HLI, particularly for income-focused investors seeking compensation for risk. When you combine a premium valuation, only Fair volatility characteristics and limited dividend support, shareholders are exposed if sentiment in the sector or company-specific expectations disappoint.

Relative to peers in Financials, Houlihan Lokey does not stand out as a clear winner. Its C (Hold) rating is in line with Berkshire Hathaway Inc. (BRKA, C) and Capital One Financial Corporation (COF, C), but lags The Goldman Sachs Group, Inc. (GS, C+) and The Charles Schwab Corporation (SCHW, C+), which earn slightly stronger Weiss Ratings without obviously higher risk.


About Houlihan Lokey, Inc.

Houlihan Lokey, Inc. (HLI) is a global investment bank operating within the Financials sector, with a primary focus on advisory-based Financial Services rather than balance sheet-intensive activities. The firm is best known for its restructuring advisory franchise, where it frequently represents creditors and distressed companies in complex capital structure negotiations, bankruptcies, and special situations. Beyond restructuring, Houlihan Lokey provides corporate finance advisory, including sell-side and buy-side mergers and acquisitions, fairness opinions, and independent valuation services for a wide range of clients, from middle-market businesses to large multinational corporations. Its practice areas are organized by industry and product, allowing it to deliver highly specialized advice across sectors such as industrials, business services, financial institutions, technology, and consumer.

The company positions itself as a specialist in situations that require detailed valuation work, intricate financial modeling, and negotiation in stressed or illiquid environments, rather than as a full-service universal bank. Its Financial Services model leans heavily on fee-based advisory assignments, which tend to be cyclical and dependent on deal flow, client confidence, and broader capital markets conditions. Houlihan Lokey also offers financial and valuation advisory services for financial reporting, tax, litigation support, portfolio valuation, and transaction opinions, often serving private equity firms, hedge funds, and corporate boards that require independent assessments. While the firm has developed a recognizable advisory brand, it operates in a highly competitive landscape against larger global investment banks and specialized boutiques, which can limit its pricing power and constrain its ability to consistently win mandates across all geographies and industry verticals.


Investor Outlook

With Houlihan Lokey, Inc. (HLI) carrying a C (Hold) Weiss Rating, investors may want to exercise caution and closely monitor how the stock trades around recent price levels, especially if broader Financials sector sentiment weakens. The Hold rating reflects a risk/reward balance that is neither compellingly positive nor severely negative, so developments in deal activity, capital markets conditions, and any rating changes could be pivotal. See full rankings of all C-rated Financials stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
NVDA NASDAQ $176.11
B
AAPL NASDAQ $259.24
B
AVGO NASDAQ $310.68
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $126.57
B
B
Top Financial Stocks
See All »
B
B
JPM NYSE $295.29
B
V NYSE $302.96
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $934.42
B
JNJ NYSE $243.32
B
AMGN NASDAQ $346.48
Top Real Estate Stocks
See All »
B
PLD NYSE $132.95